Amyotrophic Lateral Sclerosis (ALS)

ALS - Aaron Gitler, Ph.D.

Aaron Gitler, an associate professor of genetics at Stanford University in Stanford, Calif., was awarded an MDA research grant totaling $253,800 over three years to investigate how mutations in the gene for a protein called profilin 1 cause amyotrophic lateral sclerosis (ALS).

ALS - Maurizio Grimaldi, M.D., Ph.D.

Maurizio  Grimaldi, leader of the Neuropharmacology/Neuroscience Laboratory at Southern Research Institute in Birmingham, Ala., was awarded an MDA research grant totaling $253,800 over three years to study the development of molecules that have neuroprotective effects and have the potential to be used as therapies for the treatment of amyotrophic lateral sclerosis (ALS).

MDA President and CEO Takes the #ALSIceBucketChallenge

CHIGAGO, August 15, 2014 – Having a bucket of ice water dumped on your head may not seem dignified, but it is certainly helping MDA and other ALS-fighting organizations raise awareness and funds as the viral social media craze continues to sweep across America.  

Today, Steven M. Derks, President and CEO of the Muscular Dystrophy Association, joined the ranks of tens of thousands of people willing to get chilled in the ALS Ice Bucket Challenge.

ALS: BrainStorm to Test NurOwn Cells in US

Tirasemtiv May Slow Respiratory Decline in ALS

ALS: Experimental Drug Tirasemtiv Fails To Show Efficacy in Phase 2b Trial



Shape of Genetic Material Matters in C9ORF72-Related ALS

Dutch Bros. Coffee Annual “Drink One for Dane” Day to Donate Proceeds to Muscular Dystrophy Association

Leading the Way: MDA’s critical support for people with ALS

For many, amyotrophic lateral sclerosis is a fast disease. Once diagnosed, the average life expectancy for a person with ALS can be as few as three to five years. When Ben Thomas received his ALS diagnosis at the age of 29 — just three months after the birth of his only daughter, Emmerson — his world was turned upside down.

MDA is the world leader in funding ALS research and services.

New Forms of Genetic Testing Improve Diagnosis, Raise Questions

“Knowing, if not all, is almost all,” said Matthew Harms, a neurologist and neurophysiologist from Washington University in St. Louis, in his presentation on genetic testing for neuromuscular disorders at the 2014 MDA Clinical Conference, held in Chicago March 16-19.